GLP-1/glucagon receptor co-agonism for treatment of obesity
Diabetologia - Clinical and Experimental Diabetes and Metabolism Sep 16, 2017
Sánchez-Garrido MA, et al. - In this overview, researchers will target on the discovery and translational relevance of dual agonists that pharmacologically function at the receptors for glucagon and glucagon-like peptide-1. This review demonstrates that novel unimolecular, multifunctional peptides have emerged as one of the most promising medicinal approaches to enhance metabolic efficacy and restore normal body weight.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries